CryoLife (Germany) Analysis
| CYL Stock | EUR 26.65 0.10 0.37% |
CryoLife is undervalued with Real Value of 30.84 and Hype Value of 26.65. The main objective of CryoLife stock analysis is to determine its intrinsic value, which is an estimate of what CryoLife is worth, separate from its market price. There are two main types of CryoLife's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect CryoLife's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of CryoLife's stock to identify patterns and trends that may indicate its future price movements.
The CryoLife stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CryoLife's ongoing operational relationships across important fundamental and technical indicators.
CryoLife |
CryoLife Stock Analysis Notes
About 87.0% of the company shares are held by institutions such as insurance companies. The book value of CryoLife was currently reported as 7.05. The company has Price/Earnings (P/E) ratio of 303.28. CryoLife recorded a loss per share of 0.44. The entity last dividend was issued on the 9th of December 2015. The firm had 3:2 split on the 28th of December 2000. CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people. For more info on CryoLife please contact the company at 770 419 3355 or go to https://artivion.com.CryoLife Investment Alerts
| CryoLife has high likelihood to experience some financial distress in the next 2 years | |
| CryoLife has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 313.79 M. Net Loss for the year was (19.19 M) with profit before overhead, payroll, taxes, and interest of 202.52 M. | |
| CryoLife has accumulated about 40.26 M in cash with (5.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.08. | |
| Over 87.0% of the company shares are held by institutions such as insurance companies |
CryoLife Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 506.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CryoLife's market, we take the total number of its shares issued and multiply it by CryoLife's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.CryoLife Profitablity
CryoLife's profitability indicators refer to fundamental financial ratios that showcase CryoLife's ability to generate income relative to its revenue or operating costs. If, let's say, CryoLife is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, CryoLife's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of CryoLife's profitability requires more research than a typical breakdown of CryoLife's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Technical Drivers
As of the 21st of December, CryoLife shows the Downside Deviation of 1.41, risk adjusted performance of 0.1289, and Mean Deviation of 1.32. CryoLife technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CryoLife potential upside, and the relationship between the maximum drawdown and semi variance to decide if CryoLife is priced correctly, providing market reflects its regular price of 26.65 per share.CryoLife Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CryoLife middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CryoLife. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
CryoLife Outstanding Bonds
CryoLife issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CryoLife uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CryoLife bonds can be classified according to their maturity, which is the date when CryoLife has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
CryoLife Predictive Daily Indicators
CryoLife intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CryoLife stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 26.65 | |||
| Day Typical Price | 26.65 | |||
| Price Action Indicator | (0.05) | |||
| Period Momentum Indicator | (0.10) | |||
| Relative Strength Index | 56.46 |
CryoLife Forecast Models
CryoLife's time-series forecasting models are one of many CryoLife's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CryoLife's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About CryoLife Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how CryoLife prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CryoLife shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CryoLife. By using and applying CryoLife Stock analysis, traders can create a robust methodology for identifying CryoLife entry and exit points for their positions.
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding CryoLife to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Complementary Tools for CryoLife Stock analysis
When running CryoLife's price analysis, check to measure CryoLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoLife is operating at the current time. Most of CryoLife's value examination focuses on studying past and present price action to predict the probability of CryoLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoLife's price. Additionally, you may evaluate how the addition of CryoLife to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |